Fortrea Holdings, Inc. (FTRE)
20.19
+0.13
(+0.65%)
USD |
NASDAQ |
Nov 13, 16:00
20.19
0.00 (0.00%)
After-Hours: 19:59
Fortrea Holdings Enterprise Value : 2.834B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 2.834B |
| November 11, 2026 | 2.864B |
| November 10, 2026 | 2.962B |
| November 09, 2026 | 3.044B |
| November 06, 2026 | 3.017B |
| November 05, 2026 | 2.872B |
| November 04, 2026 | 2.908B |
| November 03, 2026 | 2.919B |
| November 02, 2026 | 2.830B |
| October 30, 2026 | 2.952B |
| October 29, 2026 | 3.130B |
| October 28, 2026 | 3.395B |
| October 27, 2026 | 3.255B |
| October 26, 2026 | 3.197B |
| October 23, 2026 | 3.178B |
| October 22, 2026 | 3.206B |
| October 21, 2026 | 3.220B |
| October 20, 2026 | 3.096B |
| October 19, 2026 | 3.061B |
| October 16, 2026 | 3.068B |
| October 15, 2026 | 3.093B |
| October 14, 2026 | 2.957B |
| October 13, 2026 | 2.917B |
| October 12, 2026 | 2.924B |
| October 09, 2026 | 2.909B |
| Date | Value |
|---|---|
| October 08, 2026 | 2.864B |
| October 07, 2026 | 2.882B |
| October 06, 2026 | 2.903B |
| October 05, 2026 | 2.935B |
| October 02, 2026 | 2.828B |
| October 01, 2026 | 2.770B |
| September 30, 2026 | 2.823B |
| September 29, 2026 | 2.826B |
| September 28, 2026 | 2.857B |
| September 25, 2026 | 2.840B |
| September 24, 2026 | 2.853B |
| September 23, 2026 | 2.805B |
| September 22, 2026 | 2.892B |
| September 21, 2026 | 2.853B |
| September 18, 2026 | 2.844B |
| September 17, 2026 | 2.878B |
| September 16, 2026 | 2.848B |
| September 15, 2026 | 2.825B |
| September 14, 2026 | 2.605B |
| September 11, 2026 | 2.585B |
| September 10, 2026 | 2.568B |
| September 09, 2026 | 2.546B |
| September 08, 2026 | 2.571B |
| September 04, 2026 | 2.632B |
| September 03, 2026 | 2.720B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Charles River Laboratories International, Inc. | 18.99B |
| IQVIA Holdings, Inc. | 58.70B |
| Medpace Holdings, Inc. | 17.79B |
| Champions Oncology, Inc. | 71.90M |
| Avantor, Inc. | 13.81B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.60M |
| Revenue (Quarterly) | 691.50M |
| Total Expenses (Quarterly) | 690.90M |
| EPS Diluted (Quarterly) | 0.0059 |
| Gross Profit Margin (Quarterly) | 17.28% |
| Profit Margin (Quarterly) | 0.09% |
| Earnings Yield | -3.64% |
| Operating Earnings Yield | 2.35% |
| Normalized Earnings Yield | -2.382 |